Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.2 |
mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |
mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |
mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.2 |
mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.2 |
mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |
mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |